Providing health care, education and resources around the world, wherever they are needed most.
Category Image
Keysight Report Reveals Healthcare Lags Other Industries in Software Test Automation
Keysight has released Vital Signs, a new survey that reveals that the healthcare industry lags other industries in deploying test automation practices to ensure the quality of the software that physicians use to provide patient care.
Viatris Announces Launch of Breyna™ (Budesonide and Formoterol Fumarate Dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People With Asthma and Chronic Obstructive Pulmonary Disease, in Partnership With Kindeva
Viatris Inc. and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application approved by the U.S. Food and Drug Administration (FDA).
Illumina and Pillar Biosciences Partner To Improve Access to Personalized Cancer Treatment Options
Illumina and Pillar Biosciences Inc., the pioneers of Decision Medicine™, announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.
Budi Hermawan’s Long Fight Against Tuberculosis
Nothing about Budi Hermawan’s experience with tuberculosis (TB) has been easy. In 2003, he had a cough. He didn’t think much of it, but as his symptoms worsened, he visited a doctor near his home in Bogor, Indonesia.
Accelerating Action To Decarbonize Healthcare in the U.S.
Climate-related deaths, including from air pollution, extreme temperatures, flooding and drought, are growing.
New Research Shows CGP Is Most Effective as a Standalone Test
Comprehensive genomic profiling (CGP) assesses hundreds of tumor genes to find actionable mutations and is becoming the standard of care for many cancers. However, oncologists often opt for single-gene tests (SGT) before pursuing CGP.
Viatris 2022 Sustainability Report: Partnering To End Tuberculosis
Tuberculosis (TB) is the second deadliest infectious disease, causing 1.5 million deaths globally every year. More than 80%1 of cases and deaths due to TB occur in lower- and middle-income countries.
Q4HE Collaborates With Western University of Health Sciences To Support Biopsies Save Lives
Quest Diagnostics, through the Quest for Health Equity (Q4HE) initiative, has teamed up with Western University of Health Sciences (WesternU) to offer no-cost diagnostic testing services to support Biopsies Save Lives.
Paris 2024 Gets France Moving
The Olympic Games may be a year away, but the commitment to “get France moving more”, that Paris 2024 made before it was awarded the Games, is already bringing benefits for people in the country.
Gilead Sciences: Putting a Spotlight on the Mental Health Needs of LGBTQ+ Youth
Across the country, LGBTQ+ youth face challenges that are negatively affecting their mental health. Some find themselves not feeling accepted by their family or friends, or being verbally harassed at school.